Clinical Trials Logo

Clinical Trial Summary

Prospective, 2-arm, randomised (2:1), multicentre, open-label clinical trial in patients with severe emphysema. The intervention arm will be treated with Bronchoscopic lung volume reduction in severe emphysema using thermoablation.The interventional treatment (bronchoscopic lung volume reduction) is compared with the usual conservative standard therapy (GOLD guidelines).


Clinical Trial Description

Currently, there is less data on the use of bronchoscopic thermoablation (BTVA) for the treatment of patients with emphysema. However, the current studies suggest with a high degree of certainty that bronchoscopic lung volume reduction for severe emphysema using thermoablation has the potential to be a necessary treatment alternative. The trial study should therefore contribute to proving the benefit of this procedure as an effective and safe treatment option in order to guarantee emphysema patients sufficient, appropriate and economical care, taking into account evidence-based medical knowledge. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05717192
Study type Interventional
Source IHF GmbH - Institut für Herzinfarktforschung
Contact Felix Herth, MD
Phone +49 6221 396 1200
Email felix.herth@med.uni-heidelberg.de
Status Not yet recruiting
Phase N/A
Start date January 1, 2024
Completion date January 1, 2027